Clinical Trials Logo

Filter by:
NCT ID: NCT06062173 Active, not recruiting - Radiomics Clinical Trials

Preoperative Prediction of Adherent Perirenal Fat.

APF
Start date: January 5, 2020
Phase:
Study type: Observational

In addition to kidney tumor specific factors, adherent perirenal fat is one of the most important causes of technical complications in kidney surgery, and currently, there is a lack of widely used non-invasive predictive models in clinical practice. In this study, a deep learning algorithm based on CT imaging and nomogram was proposed to identify and predict the presence of adherent perirenal fat. This study includes the construction of a prediction model based on CT imaging and the verification of the prediction model.

NCT ID: NCT06061731 Completed - Stroke Sequelae Clinical Trials

Low-frequency Electrical Stimulation of Acupuncture Points

Start date: January 1, 2022
Phase: Early Phase 1
Study type: Interventional

Abstract: Objective: To examine the effect of low-frequency acupoint electrical stimulation (LFES) on the surface electromyographic (sEMG) signals of the thumb-to-finger movement muscles in stroke patients, and to evaluate the clinical efficacy of LFES on hand function recovery after stroke.

NCT ID: NCT06061653 Recruiting - Depressive Disorder Clinical Trials

Augmentation of Interpersonal Psychotherapy With High-Definition Transcranial Direct Current Stimulation for Adolescent Depression

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Depression is among the most prevalent psychiatric disorders, with an upward trend in its manifestation in younger individuals. In contrast to adult depression, adolescent depression often presents with longer attack durations, higher recurrence rates, chronicity, and elevated disability rates. At present, treatment options for adolescent depression encompass pharmacological, physical, and psychological therapies. However, current evidence suggests that no antidepressant medication is entirely safe for youths, with only fluoxetine and escitalopram being FDA-approved for treating adolescent depression. Given the weight of interpersonal stressors faced by teenagers, the NICE guidelines recommend interpersonal therapy(IPT) as a first-line treatment. A 2020 meta-analysis in the Journal of the American Academy of Child and Adolescent Psychiatry reported that interpersonal therapy exhibited significantly greater improvements in depression symptoms than cognitive behavioral therapy(CBT), although psychotherapeutic effects were modest, achieving a remission rate of 60%. These results underscore the need for further research to enhance interpersonal therapy's effectiveness in treating adolescent depression. High-Definition Transcranial Direct Current Stimulation (HD-tDCS)is a highly secure non-invasive brain stimulation technique that produces sustained effects even after stimulation has discontinued, rendering it particularly valuable for therapeutic interventions. The proposed study aims to augment a single IPT treatment with HD-tDCS stimulation for adolescent depression. By enhancing the excitability of the cerebral cortex, HD-tDCS could potentially enhance IPT's therapeutic efficacy in treating adolescent depression while facilitating further investigation of its underlying neural circuit mechanisms.

NCT ID: NCT06061640 Active, not recruiting - Clinical trials for Metabolic Dysfunction-associated Fatty Liver Disease

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Start date: June 1, 2023
Phase:
Study type: Observational

This is a case-control study that aims to build a predictive model for MAFLD based on machine learning.

NCT ID: NCT06061627 Recruiting - Heart Failure Clinical Trials

A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD

BATTLE
Start date: September 21, 2023
Phase: N/A
Study type: Interventional

BATTLE study has been designed as a prospective, multi-center, randomized, controlled trial. This study will enroll 83 patients with chronic heart failure accompanied by intraventricular block (NICD) over an estimated recruitment period of 3 years. An LOT-CRT group will be compared with a group of conventional BiVP in the follow-up of at least 6 months. The study aimed to compare the curative effect of LOT-CRT in preserving LV systolic function with traditional BiVP in chronic heart failure patients with NICD.

NCT ID: NCT06061614 Recruiting - Phenylketonurias Clinical Trials

Safety and Efficacy Study of NGGT002 in PKU Adult Subjects

Start date: March 30, 2023
Phase: Early Phase 1
Study type: Interventional

This investigator initiated trial is an open-label, dose escalation study to evaluate the safety, tolerability and efficacy of NGGT002, an AAV derived investigational gene therapy product expressing human PAH enzyme in adult Phenylketonuria (PKU) subjects with PAH deficiency. All participants will receive a single administration of NGGT002 and will be followed for safety and efficacy for 5 years.

NCT ID: NCT06061536 Recruiting - HIV Clinical Trials

Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.

Start date: November 2, 2023
Phase: Phase 2
Study type: Interventional

A randomized, controlled, open-label, dose-exploration study to assess the effectiveness and safety of Lipovirtide combined with nucleoside drugs in HIV-infected patients who have not received antiviral treatment before.

NCT ID: NCT06061510 Completed - Clinical trials for Type 2 Diabetes Mellitus

Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus

Start date: June 8, 2019
Phase: N/A
Study type: Interventional

The objective of this research was to investigate the impact of Omega-3 PUFAs on the gut microbiota and serum lipid metabolites in participants diagnosed with type 2 diabetes, employing high-throughput sequencing technology and untargeted lipidomics.

NCT ID: NCT06061471 Recruiting - Psoriasis Clinical Trials

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

Start date: September 14, 2023
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK111 in the treatment of subjects with moderate to severe plaque psoriasis.

NCT ID: NCT06061445 Recruiting - Clinical trials for Stage IIIA Hepatocellular Carcinoma

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma

Start date: January 9, 2024
Phase: N/A
Study type: Interventional

The purpose of this clinical research study is to investigate the efficacy and safety of Radiotherapy Combined with TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma with Portal Vein Tumor Thrombus(PVTT).